Invasive fungal infections and (1,3)-β-d-glucan serum concentrations in long-term intensive care patients

International Journal of Infectious Diseases

Volumn 13, Issue 6, 2009, Pages 707-712

  Presterl, Elisabeth ^a   Parschalk, Bernhard ^a   Bauer, Edith ^a   Lassnigg, Andrea ^a   Hajdu, Stefan ^a   Graninger, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

(1,3) d Glucan; Diagnosis; Fungal infection; Intensive care unit

Indexed keywords

(1,3)BETA DEXTRO GLUCAN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; CASPOFUNGIN; FLUCONAZOLE; GLUCAN; UNCLASSIFIED DRUG; VORICONAZOLE;

ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; CANDIDEMIA; CANDIDIASIS; COMORBIDITY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; FEMALE; HEPATITIS; HOSPITAL ADMISSION; HUMAN; INFECTION RATE; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PERITONITIS; POSTOPERATIVE PERIOD; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ASPERGILLOSIS; ASPERGILLUS; BETA-GLUCANS; CANDIDA; CANDIDIASIS; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MYCOSES; PREDICTIVE VALUE OF TESTS;

EID: 70349202639     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.10.013     Document Type: Article

References (19)

1. Wenzel R.P. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 20 (1995) 1531-1534
2. Leleu G., Aegerter P., and Guidet B. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 17 (2002) 168-175
3. Meersseman W., Vandecasteele S.J., Wilmer A., Verbeken E., Peetermans W.E., and Van Wijngaerden E. Invasive Aspergillosis in Critically Ill Patients without Malignancy. Am J Respir Crit Care Med 170 (2004) 621-625
4. Yeo S.F., and Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 15 (2002) 465-484
5. Iwanaga S., Miyata T., Tokunaga F., and Muta T. Molecular mechanism of hemolymph clotting system in Limulus. Thromb Res 68 (1992) 1-32
6. Digby J., Kalbfleisch J., Glenn A., Larsen A., Browder W., and Williams D. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10 (2003) 882-885
7. Nett J., Lincoln L., Marchillo K., and Andes D. Beta-1,3 glucan as a test for central venous catheter biofilm infection. J Infect Dis 195 (2007) 1705-1712
8. Pickering J.W., Sant H.W., Bowles C.A., Roberts W.L., and Woods G.L. Evaluation of a (1→3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43 (2005) 5957-5962
9. Persat F., Ranque S., Derouin F., Michel-Nguyen A., Picot S., and Sulahian A. Contribution of the (1→3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 46 (2008) 1009-1013
10. Pittet D., Monod M., Suter P.M., Frenk E., and Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220 (1994) 751-758
11. Leon C., Ruiz-Santana S., Saavedra P., Almirante B., Nolla-Salas J., Alvarez-Lerma F., et al. A bedside scoring system ('Candida score') for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med 34 (2006) 730-737
12. Bille J., Marchetti O., and Calandra T. Changing face of health-care associated fungal infections. Curr Opin Infect Dis 18 (2005) 314-319
13. Yera H., Sendid B., Francois N., Camus D., and Poulain D. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur J Clin Microbiol Infect Dis 20 (2001) 864-870
14. Sendid B., Caillot D., Baccouch-Humbert B., Klingspor L., Grandjean M., Bonnin A., et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 41 (2003) 4551-4558
15. van Deventer A., van Vliet H., Hop W.C., and Goessens W.H. Diagnostic value of anti-Candida enolase antibodies. J Clin Microbiol 32 (1994) 17-23
16. Odabasi Z., Mattiuzzi G., Estey E., Kantarjian H., Saeki F., Ridge R.J., et al. Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39 (2004) 199-205
17. Obayashi T., Yoshida M., Mori T., Goto H., Yasuoka A., Iwasaki H., et al. Plasma (1→3)-beta-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345 (1995) 17-20
18. Ostrosky-Zeichner L., Alexander B.D., Kett D.H., Vazquez J., Pappas P.G., Saeki F., et al. Multicenter clinical evaluation of the (1→3) beta-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 41 (2005) 654-659
19. Senn L., Robinson J.O., Schmidt S., Knaup M., Asahi N., Satomura S., et al. 1,3-Beta-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 46 (2008) 878-885